Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

On The Pen: The Weekly Dose 4/23/24

On The Pen: The Weekly Dose 4/23/24

FromOn The Pen: The Weekly Dose


On The Pen: The Weekly Dose 4/23/24

FromOn The Pen: The Weekly Dose

ratings:
Length:
15 minutes
Released:
Apr 23, 2024
Format:
Podcast episode

Description

New obesity medicine company launches, Lilly expands manufacturing capacity with acquisition, and TikTok censors my content.Email Alerts: https://www.onthepen.com/emailsBECOME A MEMBER HERE TO WATCH THE VIDEO:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/joinNew Obesity Medicine Company Launches: https://metsera.com/newsLilly Acquires Nexus Facility: https://finance.yahoo.com/news/lilly-buy-injectable-drug-plant-175000782.htmlTikTok Mounjaro Zepbound Censorship: https://www.bloomberg.com/news/articles/2024-04-22/tiktok-ozempic-influencers-say-new-rules-unfairly-target-themSOCIAL LINKShttps://www.tiktok.com/@manonthemounjarohttps://twitter.com/ManOnMounjarohttps://instagram.com/manonthemounjarohttps://facebook.com/manonthemounjaroThank you for tuning in! If you found this content valuable, make sure to like, share, and subscribe to my youtube channel for more updates on GLP-1, obesity, type 2 diabetes, and the latest news on Mounjaro, Zepbound, Wegovy, and Ozempic. Stay informed and entertained with my unique blend of breaking news, humor, and my personal journey. For in-depth articles and resources, visit my website at onthepen.com. You can also connect with me on social media, where I go by @manonthemounjaro (or @manonmounjaro on X). Let's continue this journey together towards a healthier and happier life!
Released:
Apr 23, 2024
Format:
Podcast episode

Titles in the series (33)

Get your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!